Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urine Growth Factors in BPH Patients Treated with Silodosin
NCT06282731Phase 1Completed
- Sponsor
- En Chu Kong Hospital
- Start
- May 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of silodosin in benign prostatic hyperplasia (BPH), sponsored by En Chu Kong Hospital. Primary endpoint: Urine growth factors level (NGF, BDNF, VEGF) at 1 month. Started May 2013; status: completed.
02
Drugs
silodosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT06282731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06282731.